MyAverix Finance
NS · Pharmaceuticals
Dishman Carbogen Amcis Ltd (DCAL)
Pharmaceuticals & Biotechnology
Dishman Carbogen Amcis Ltd (DCAL) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $27.24B, P/E ratio is -70.92, net margin is -11.3%, dividend yield is 0.12%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for DCAL
Dishman Carbogen Amcis Ltd (DCAL) — FAQ
What is Dishman Carbogen Amcis Ltd's market cap?
Dishman Carbogen Amcis Ltd (DCAL) has a reported market cap of $27.24B (data as of 2026-07-10).
What is DCAL's P/E ratio?
The price-to-earnings (P/E) ratio for Dishman Carbogen Amcis Ltd (DCAL) is -70.92 (data as of 2026-07-10).
Does Dishman Carbogen Amcis Ltd pay a dividend?
Dishman Carbogen Amcis Ltd (DCAL) shows a reported dividend yield of 0.12%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).
What sector is Dishman Carbogen Amcis Ltd in?
Dishman Carbogen Amcis Ltd (DCAL) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is DCAL listed on?
DCAL is listed on NS.
What is Dishman Carbogen Amcis Ltd's net margin?
Dishman Carbogen Amcis Ltd (DCAL) reports a net margin of -11.3% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.